Novo Nordisk shares surge as Wegovy sales drive profit beat

Shares of Novo Nordisk climbed 4.5% on Wednesday after the Danish pharmaceutical giant reported a stronger-than-expected fourth-quarter net profit, driven by soaring demand for its obesity treatment, Wegovy. However, the company warned that sales growth could slow in 2025 as competition intensifies in the weight-loss drug market. Net profit for the fourth quarter surged 29% […]